Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Inkef Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
Inkef Capital

Inkef Capital

Operating

INKEF Capital B.V. is a Netherlands-based venture capital firm specializing in technology, healthcare, media, and communication sectors.

Location
Amsterdam, North Holland, NL
Founded
2010
Firm
Compare
Portfolio
Employees
Website

INKEF Capital B.V. is a Netherlands-based venture capital firm specializing in investments in the technology, healthcare, media, and communication sectors. The firm typically participates in various stages of funding, including Seed, Series A, Series B, Series C, Series D, Series E, and Post-IPO Equity rounds. Their investment approach emphasizes patience over quick exits and prioritizes people over valuations.

Notable portfolio companies include Ambagon Therapeutics, Lengoo, QurAlis, Rainier Therapeutics, Remote, and Shapeways. INKEF Capital's investment philosophy focuses on long-term value creation and fostering meaningful dialogue with their portfolio companies. They offer unique value-add services by leveraging their extensive network and expertise to support the growth and success of their investments.

Inkef Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments10
Current Portfolio Count6
Total Portfolio Exits0

Top Investment Stages

Series B3 (37.5%)
Series A2 (25.0%)
Post Ipo Equity1 (12.5%)
Seed1 (12.5%)
Series C1 (12.5%)

Stage Mix

Series B 38%Series A 25%Post Ipo Equity 13%Seed 13%Series C 13%

Concentration shown as share of disclosed investments by stage.

Recent Investments

QurAlis logo

QurAlis

Ambagon Therapeutics logo

Ambagon Therapeutics

Shapeways logo

Shapeways

Lengoo logo

Lengoo

Remote logo

Remote

Rainier Therapeutics logo

Rainier Therapeutics

Inkef Capital - Similar Investment Firms

Innovations Kapital logo

Innovations Kapital

innkap.com

Ince Capital logo

Ince Capital

incecap.com

Tiin Capital logo

Tiin Capital

tincapital.vc

Inference Partners logo

Inference Partners

INP Capital logo

INP Capital

inp-capital.com

InFocus Capital Partners logo

InFocus Capital Partners

KPN Ventures logo

KPN Ventures

kpnventures.com

Purple Ventures logo

Purple Ventures

Assiduity Capital logo

Assiduity Capital

Inven Capital logo

Inven Capital

invencapital.cz

Innovation Capital logo

Innovation Capital

Invest-NL logo

Invest-NL

invest-nl.nl

Indico Capital Partners logo

Indico Capital Partners

indicocapital.com

INcapital Ventures logo

INcapital Ventures

incapitalvc.com

Innogest Capital logo

Innogest Capital

Inkef Capital - Classification

Also Known As
  • Inkef Capital B.V.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end